Who has invested in Congenica?

Cambridge Innovation Capital, Amadeus Capital Partners, Sanford Health are named among the investors backing Congenica.

Congenica Funding: $82M Raised, Series C (2020)

Congenica funding overview

Congenica is a Biotechnology company. Congenica has raised $82M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in November 2020. The round record for Congenica runs through 2020; nothing later has been disclosed. Investors on record include Cambridge Innovation Capital, Amadeus Capital Partners, Sanford Health. 3 distinct backers are named across the disclosed rounds.

Congenica at a glance

Total raised: $82M
Latest round: Series C
Latest round date: November 2020
Industry: Biotechnology
Notable investors: Cambridge Innovation Capital, Amadeus Capital Partners, Sanford Health

Frequently asked about Congenica funding

How much has Congenica raised?: Congenica has raised $82M in total disclosed funding across the rounds on record.
Who has invested in Congenica?: Cambridge Innovation Capital, Amadeus Capital Partners, Sanford Health are named among the investors backing Congenica.
What was the latest Congenica funding round?: The most recent disclosed round is a Series C, announced in November 2020.
Where is Congenica based?: No headquarters location is disclosed for Congenica.
What sector does Congenica operate in?: Congenica is tracked under Biotechnology, with $82M in disclosed funding.
When did Congenica last raise?: The last disclosed Congenica round closed in November 2020 at Series C.

Congenica totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotechnology companies below to benchmark round size and investor mix.

Congenica Funding: $82M Raised, Series C (2020)

Congenica funding overview

Congenica at a glance

Frequently asked about Congenica funding

Companies related to Congenica (14)

Browse related funding lists (5)